Micron Solutions (Micron Solutions) Debt-to-EBITDA : -2.56 (As of Mar. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Micron Solutions Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Micron Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $2.50 Mil. Micron Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $2.88 Mil. Micron Solutions's annualized EBITDA for the quarter that ended in Mar. 2023 was $-2.10 Mil. Micron Solutions's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 was -2.56.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Micron Solutions's Debt-to-EBITDA or its related term are showing as below:

MICRD's Debt-to-EBITDA is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Micron Solutions Debt-to-EBITDA Historical Data

The historical data trend for Micron Solutions's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Micron Solutions Debt-to-EBITDA Chart

Micron Solutions Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

7.47

-21.55

1.62

1.23

-17.66

Micron Solutions Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Debt-to-EBITDA	Get a 7-Day Free Trial															-2.53	26.47	20.97	26.66	-2.56

Competitive Comparison of Micron Solutions's Debt-to-EBITDA

For the Medical Devices subindustry, Micron Solutions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Micron Solutions's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Micron Solutions's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Micron Solutions's Debt-to-EBITDA falls into.

Micron Solutions Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Micron Solutions's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2.472	+	2.966)	/	-0.308
	=	-17.66

Micron Solutions's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2.503	+	2.88)	/	-2.1
	=	-2.56

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2023) EBITDA data.

Micron Solutions (OTCPK:MICRD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Micron Solutions Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Micron Solutions's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Micron Solutions (Micron Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Micron Solutions Inc (OTCPK:MICRD) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

25 Sawyer Passway, Fitchburg, MA, USA, 01420

Website

https://www.micronsolutionsinc.com

Micron Solutions Inc is a diversified contract manufacturing organization that produces engineered medical device components requiring precision machining and injection molding. It provides design, engineering, quality, and regulatory expertise across the three product lines, machining, thermoplastic injection molding, and sensors. It's engaged in the production and sale of silver chloride-coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. It also provides other value-added services, including the design, manufacture, and rehabilitation of injection molding tools, pad printing, ultrasonic welding, stamping, laser marking, clean room molding, and others.

Executives

Steven D. Heinemann	10 percent owner	C/O GOOSE HILL CAPITAL, 546 FIFTH AVENUE, 14TH FLOOR, NEW YORK NY 10036
Wayne M Coll	officer: CFO
Rodd Friedman	director, 10 percent owner	12 SOUTH MAIN STREET, SUITE 203, NORWALK CT 06854
Jason Russell Chambers	director	4355 COBB PKWY, SUITE J BOX 269, ATLANTA 2Q 30339
Robert A Mello	director	C/O IRIS INTERNATIONAL, INC., 9158 ETON AVENUE, CHATSWORTH CA 91311
William J. Laursen	director, officer: Chief Executive Officer	13 PENINSULA ROAD, HARVARD MA 01451
Andrei Soran	director	28 LOTHROP STREET, NEWTON MA 02460
Bryan Ganz	director	C/O ARRHYTHMIA RESEARCH TECHNOLOGY, INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420
Ref Securities & Co.	10 percent owner	12 SOUTH MAIN STREET, SUITE 203, NORWALK CT 06854
Marco Benedetti	director	9645 WEHRLE DRIVE, CLARENCE NY 14031
Salvatore Jr Emma	director, officer: PRESIDENT and CEO	20 LONGLEY ROAD, SHIRLEY MA 01464
Derek Thomas Welch	officer: Prin.Financial & Accounting	405 NEW WEST TOWNSEND ROAD, LUNENBURG MA 01462
Patrick L Muldoon	director	215 HUBBARDSTON ROAD, PRINCETON MA 01541
Michael S Gunter	director	104 CAMBRIDGE PLAZA DRIVE, WINSTON-SALEM NC 27104
Michael Francis Nolan	officer: Chief Operating Officer	25 SAWYER PASSWAY, FITCHBURG MA 01420